Schedule 13G ownership disclosure
ACUTUS MED INC
Common Stock, par value $0.001 per share · CUSIP: 005111109
Event date: 2025-07-09
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Advent Life Sciences LLP
Shares: 0 · Class: 0%
- Advent Life Sciences Fund I LP
Shares: 0 · Class: 0%
- Shahzad Malik
Shares: 22,757 · Class: 0.07608%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001062993-26-001018
- Form type
- SCHEDULE 13G/A
- Filer
- Acutus Medical, Inc.
- CIK
- CIK 1522860
- Filed
- Feb 17, 2026
- Reporting period
- Jul 09, 2025
- Description
- Schedule 13G beneficial ownership